The IHC images obtained from HPA indicated that these seven PRGs (except ADORA3) expressed in human colorectal cancer, breast cancer, prostate cancer, lung cancer, and Non-Hodgkin’s Lymphoma. Here, ADORA3 is linked to prostate carcinoma.